Pulmonary rehabilitation in interstitial lung diseases: A review of the literature

Advances in Clinical and Experimental Medicine

Volumn 29, Issue 2, 2020, Pages 257-264

  Wytrychowski, Krzysztof ^a   Hans Wytrychowska, Anna ^a   Piesiak, Paweł ^a   Majewska Pulsakowska, Marta ^a   Rozek Piechura, Krystyna ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

Author keywords

Airway management; Interstitial lung diseases; Pulmonary rehabilitation

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; EXERCISE TOLERANCE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; PATHOGENESIS; PATIENT CARE; PULMONARY REHABILITATION; RESPIRATORY FAILURE; KINESIOTHERAPY; PREVALENCE;

EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; LUNG DISEASES, INTERSTITIAL; PREVALENCE;

EID: 85081945297     PISSN: 18995276     EISSN: 24512680     Source Type: Journal    
DOI: 10.17219/acem/115238     Document Type: Article

References (42)

1. Wiatr E. Definicja i klasyfikacje chorób śródmia¸zszowych płuc. In: Wiatr E, Rowińska-Zakrzewska E, Pirozyński M, eds. Choroby śródmia¸zszowe płuc. Bielsko-Biała, Poland: Alfa Medica Press; 2012:15-20.
2. Boros P. Zaburzenia czynnościowe w chorobach śródmia¸zszowych płuc. In: Wiatr E, Rowińska-Zakrzewska E, Pirozyński M, eds. Choroby śródmia¸zszowe płuc. Bielsko-Biała, Poland: Alfa Medica Press; 2012: 48-61.
3. Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, et al. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J. 2017;50(2). pii: 1602419. doi:10. 1183/13993003.02419-2016
4. Interstitial Lung Diseases - ERS. https://www.erswhitebook.org/chapters/interstitial-lung-diseases/.
5. Meyer KC. Diagnosis and management of interstitial lung disease. Transl Respir Med. 2014;2:4. doi:10.1186/2213-0802-2-4
6. Loveman E, Copley VR, Colquitt J, et al. The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: A systematic review and economic evaluation. Health Technol Assess. 2015;19(20):i-xxiv,1-336.
7. Nici L, Donner C, Wouters E, et al; ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-1413.
8. Spruit MA, Singh SJ, Garvey C, et al; ATS/ERS Task Force on Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2013;188(8):1011-1027.
9. Rochester CL, Vogiatzis I, Holland AE, et al; ATS/ERS Task Force on Policy in Pulmonary Rehabilitation. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation. Am J Respir Crit Care Med. 2015;192(11):1373-1386.
10. Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: A call for continued investigation. Respir Med. 2008;102(12):1675-1680.
11. Flaherty KR, Thwaite E, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: Survival implications. Thorax. 2003;58(2):143-148.
12. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63(6):549-554.
13. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394-399.
14. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev. 2008;4:CD006322.
15. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166(1):111-117.
16. du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis: Test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011;183(9):1231-1237.
17. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Small changes in six-minute walk distance are important in diffuse parenchymal lung disease. Respir Med. 2009;103(10):1430-1435.
18. Bajwah S, Ross JR, Peacock JL, et al. Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: A systematic review of the literature. Thorax. 2013;68(9):867-879.
19. Swigris JJ, Fairclough DL, Morrison M. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care. 2011;56(6): 783-789.
20. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2014;10:CD006322.
21. Gomes-Neto M, Silva CM, Ezequiel D, Conceição CS, Saquetto M, Machado AS. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis. J Cardiopulm Rehabil Prev. 2018;38(5):273-278.
22. Huppmann P, Szczepanski B, Boensch M, et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J. 2013;42(2):444-453.
23. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: Prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med. 2006;174(7):803-809.
24. Kizer JR, Zisman DA, Blumenthal NP, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med. 2004; 164(5):551-556.
25. King C, Nathan SD. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases. Curr Opin Pulm Med. 2013;19(5):466-473.
26. Sherner J, Collen J, King CS, Nathan SD. Pulmonary hypertension in idiopathic pulmonary fibrosis: Epidemiology, diagnosis and therapeutic implications. Curr Respir Care Rep. 2012;1(4):233-242.
27. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114(14): 1482-1489.
28. de Man FS, Handoko ML, Groepenhoff H, et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;34(3):669-675.
29. Fox BD, Kassirer M, Weiss I, et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail. 2011;17(3):196-200.
30. Holland AE, Fiore JF Jr, Bell EC, et al. Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology. 2014;19(8):1215-1221.
31. Cottin V, Nunes H, Brillet P-Y, Delaval P. Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity. Eur Respir J. 2005;26(4):586-593.
32. Holland AE, Hill CJ, Glaspole I, Goh N, Mc-Donald CF. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir Med. 2012;106(3):429-435.
33. Deniz S, Şahin H, Yalniz E. Does the severity of interstitial lung disease affect the gains from pulmonary rehabilitation? Clin Respir J. 2018;12(6):2141-2150.
34. Ryerson CJ, Cayou C, Topp F, et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study. Respir Med. 2014;108(1):203-210.
35. Perez-Bogerd S, Wuyts W, Barbier V, et al. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial. Respir Res. 2018;19(1):182.
36. da Fontoura FF, Berton DC, Watte G, et al. Pulmonary rehabilitation in patients with advanced idiopathic pulmonary fibrosis referred for lung transplantation. J Cardiopulm Rehabil Prev. 2018;38(2): 131-134.
37. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13(3):394-399.
38. Leach RM, Davidson AC, Chinn S, Twort CH, Cameron IR, Bateman NT. Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax. 1992;47(10):781-789.
39. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Statement. Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med. 2011; 183(6):788-824.
40. Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: Benefits and predictors of response. Chest. 2009;135(2):442-447.
41. Keyser RE, Christensen EJ, Chin LM, Woolstenhulme JG. Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease. Respir Med. 2015;109(4):517-525.
42. Vainshelboim B, Myers J, Oliveira J, Izhakian S, Unterman A, Kramer MR. Physiological responses and prognostic value of common exercise testing modalities in idiopathic pulmonary fibrosis. J Cardiopulm Rehabil Prev. 2018 Sep 24 [Epub ahead of print]. doi:10.1097/HCR.0000000000000362